| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Harmony Biosciences Holdings, Inc.'s insiders have reduced their positions by a net 72,406 shares worth roughly $3.1M.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 24.5K | $907.8K | - | |
| Other | 13.1K | $485.5K | - | |
| CEO | 7.3K | $271.9K | - | |
| Other | 4.3K | $160.2K | - | |
| Other | 1.5K | $54.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 6, 2022 | Jeffrey Dierks62 | Chief Commercial Officer | Sale+OE | 6,125 | $40.37 | $247,257.80 | - | +22.1% | +32.6% | |
| Jan 4, 2022 | John C Jacobs53 | President, CEO | Sale+OE | 28,700 | $45.16 | $1,295,985.26 | - | +15.2% | +24.2% | |
| Dec 27, 2021 | John C Jacobs53 | President, CEO | Sale+OE | 1,300 | $45.03 | $58,538.48 | - | +16.1% | +26.0% | |
| Dec 13, 2021 | John C Jacobs53 | President, CEO | Sale+OE | 25,000 | $38.22 | $955,408.59 | - | +10.9% | +54.9% | |
| Dec 10, 2021 | Andreas Wicki71 | Director | Sell | 27,268 | $40.09 | $1,093,148.27 | -0.6% | +19.7% | +54.8% | |
| Nov 17, 2021 | Andreas Wicki71 | Director | Sell | 69,268 | $41.60 | $2,881,692.84 | -1.5% | -0.9% | +39.7% | |
| Nov 1, 2021 | Jeffrey Dierks62 | Chief Commercial Officer | Sale+OE | 10,000 | $41.67 | $416,739.50 | - | -16.6% | +37.8% | |
| Oct 19, 2021 | Jeffrey M. Dayno54 | Chief Medical Officer | Sale+OE | 18,200 | $43.27 | $787,542.81 | - | -16.4% | +19.8% | |
| Oct 6, 2021 | Jeffrey M. Dayno54 | Chief Medical Officer | Sale+OE | 1,800 | $40.10 | $72,178.56 | - | +10.1% | +22.4% | |
| Sep 13, 2021 | John C Jacobs53 | President, CEO | Sale+OE | 25,000 | $35.93 | $898,262.50 | - | +5.9% | +26.9% |